CUSIP No.: 04301G201

 

Exhibit 1

 

Joint Filing Statement

Pursuant to Rule 13d-1(k)(1)

 

The undersigned hereby consent and agree to the joint filing of Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Common Stock, par value $0.001 per share of Artelo Biosciences, Inc. beneficially owned by them, together with any or all amendments thereto, when and if appropriate. The parties hereto further consent and agree to file this Joint Filing Statement pursuant to Rule13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule13G.

 

This Joint Filing Statement may be terminated by any of the undersigned upon written notice or such lesser period of notice as the undersigned may mutually agree.

 

Dated: February 9, 2022  
   
  Parian Global Management LP
  By: CCZG LLC, its General partner
   
  By: /s/ Zachary C. Miller
    Zachary C. Miller, Managing Member
   
  Parian Global Master LP
  By: Parian Global Management LP, its Investment Manager
  By: CCZG LLC, the General Partner of the Investment Manager
   
  By: /s/ Zachary C. Miller
    Zachary C. Miller, Managing Member  
   
  CCZG LLC
   
  By: /s/ Zachary C. Miller
    Managing Member
   
  Zachary C. Miller
   
  By: /s/ Zachary C. Miller
    Zachary C. Miller